0001179110-17-010227.txt : 20170707 0001179110-17-010227.hdr.sgml : 20170707 20170707165712 ACCESSION NUMBER: 0001179110-17-010227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170705 FILED AS OF DATE: 20170707 DATE AS OF CHANGE: 20170707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Ravindra CENTRAL INDEX KEY: 0001586835 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 17955741 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2017-07-05 0 0001280600 ACCELERON PHARMA INC XLRN 0001586835 Kumar Ravindra 128 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP & Chief Scientific Officer Common Stock 2017-07-05 4 M 0 937 7.12 A 96264 D Common Stock 2017-07-05 4 S 0 937 32.00 D 95327 D Option to Purchase Common Stock 7.12 2017-07-05 4 M 0 937 0 D 2022-12-12 Common Stock 937 0 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant. /s/ John D. Quisel, as attorney-in-fact for Ravindra Kumar 2017-07-07